-- モロッコ・ストラテジック・ミネラルズ（MCC.V）は、月曜日に株式ユニットの私募により500万ドルを調達する計画を発表した。株価は直近の取引で14%下落している。 同社は、1ユニットあたり0.15ドルで最大3,330万ユニットを発行する予定で、各ユニットは1株と、0.25ドルで1株を購入できる2年間のワラントの半分で構成される。 調達資金は、モロッコにおける鉱山資産の取得および開発資金に充当される。 モロッコ・ストラテジックの株価は、トロント証券取引所ベンチャー市場で直近の取引で0.03ドル安の0.15ドルとなっている。
Price: $0.15, Change: $-0.03, Percent Change: -14.29%
(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.
Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.
Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.